Serum fibroblast growth factor 19 (FGF19) levels are associated with atherogenic dyslipidemia in patients with type 2 diabetes.
- Author:
Jing-Yi HU
1
;
Hai-Lan ZOU
1
;
Yan-Hua LI
1
;
Dong-Ying NIE
1
;
Chen CHAO
1
;
Jin-Han LIU
1
;
Jin DING
1
;
Zhi-Guang ZHOU
1
;
Yang XIAO
1
Author Information
- Publication Type:Letter
- MeSH: Atherosclerosis; Diabetes Mellitus, Type 2/complications*; Dyslipidemias; Fibroblast Growth Factors; Humans
- From: Chinese Medical Journal 2021;134(18):2243-2245
- CountryChina
- Language:English
